NeuroFlow, the leading provider of behavioral health technology infrastructure, announced that it has acquired Owl, a measurement-based care technology company. The deal creates a suite of solutions that extends the delivery of feedback-informed care across healthcare settings, positioning NeuroFlow as the unparalleled market leader in behavioral health measurement and engagement.
Building upon NeuroFlow’s 2023 acquisition of Capital Solution Design, a measurement-based care solution for the U.S. Department of Veterans Affairs, the acquisition of Owl now extends NeuroFlow’s capabilities into behavioral health provider organizations. This allows NeuroFlow’s platform to integrate across primary and specialty care settings to provide a 360-degree view of a population’s behavioral health risk. The breadth of this enhanced platform will empower NeuroFlow and its partners to address systemic barriers to behavioral health access across providers, health plans, and the federal government.
“Behavioral health conditions are present everywhere, not just in behavioral health clinics, and in many cases those conditions go unidentified or untreated, leading to higher costs and worse clinical outcomes. That is why NeuroFlow has historically been focused on upstream needs with payers, primary care, and other multi-specialty providers,” explained NeuroFlow Chief Executive Officer Chris Molaro. “As the leading measurement-based care solution for behavioral health providers, Owl provides a comprehensive solution for monitoring patients who need a higher level of care, giving providers the tools to track and measure outcomes over time and ensure quality and consistency throughout the care journey. This is just the beginning; we intend to build on this comprehensive foundation to improve access and engagement.”
This merger creates the largest end-to-end behavioral health measurement solution in the market, allowing providers across the continuum to identify and stratify behavioral health needs and coordinate care appropriately. This commitment to disciplined quality monitoring and outcomes tracking bolsters an area of the healthcare system that has desperately needed innovation.
“Owl is dedicated to improving clinical outcomes in partnership with behavioral health providers and demonstrating meaningful savings for the healthcare ecosystem,” says Eric Meier, Chief Executive Officer at Owl, who will serve as NeuroFlow‘s President of Behavioral Health Markets. “We’re looking forward to expanding the impact of our technology with NeuroFlow’s team and resources. Together, our organizations will provide a truly comprehensive solution that simplifies identification of individuals in need of behavioral health care and guides them through their treatment journey. Ultimately, this merger means we can make the greatest impact on behavioral health outcomes across the healthcare spectrum.”
SOURCE: PRWeb